How Meta's 2026 health and wellness restrictions changed clinic ads forever

What actually changed

Meta's health and wellness policy already restricted before/after weight imagery, personal-attribute targeting, and pharmacy-without-LegitScript advertising. The 2026 update did three new things at once:

1. Expanded the "personal attributes" definition to cover implied condition targeting — any phrasing that suggests the viewer has a specific health state, even when it's a question or hypothetical.
2. Restricted compounded-medication imagery beyond what LegitScript-certified merchants previously had to navigate — including visual depictions of vials, syringes, and injection pens when paired with weight, appearance, or wellness-outcome copy.
3. Tightened the consultation-vs-prescription distinction. Ads can still promote a clinic consultation as the offer. Ads that imply a specific prescription outcome from the consultation are now rejected at much higher rates.

The 9-clause breakdown

Here's the practical decomposition we use when auditing creative before submission. Each clause is a category of language or imagery that triggers rejections under the updated policy.

1. Personal-state interrogatives."Struggling with low T?", "Tired of feeling tired?", "Can't lose weight?". Even as questions, these target presumed personal attributes. Rephrase to category statements: "Hormone optimization for men over 40."
2. Quantitative outcome promises."Lose 20 lbs in 3 months," "Boost T levels by 40%," "Drop 4 dress sizes." Specific results, even when truthful and citation-backed, fail review. Replace with qualitative process language: "Medically supervised weight management."
3. Before/after comparisons. Side-by-side photos of patients, scale shots, body-measurement reveals. Universal rejection. Use clinical environment photography, team headshots, or facility shots instead.
4. Compounded-medication brand or generic names."Semaglutide," "Tirzepatide," "Sermorelin" in ad copy or imagery (vials with labels). Refer to programs by clinical category: "GLP-1 program," "Growth hormone peptide protocol."
5. Implied-individual targeting in static imagery.A photo of one person captioned with "You could feel like this" or similar projection. Even unspoken, the implied second-person framing is read as personal-attribute targeting.
6. Symptom checklists."Low energy? Brain fog? Weight gain?" Lists like this used to be a workhorse format. Now they map directly to multiple violation categories at once.
7. Pharmacy-flavored copy."Get your prescription delivered," "Affordable [drug name] without insurance," "Same-day shipping on peptides." The clinic is the offer; the prescription is not.
8. Unverified clinical-authority claims."The #1 provider," "Trusted by 10,000 patients," "Doctor-endorsed." These require substantiation Meta's reviewers will not look up. They reject conservatively.
9. Landing pages that violate the same rules. Even compliant ad creative gets pulled if it points to a landing page with banned imagery, before/ afters, or personal-attribute copy. Audit the LP at the same time as the ad.

What still works

The compliant-creative pattern that's clearing review in 2026 looks roughly the same across the clinics we run ads for:

• Clinic-environment photography — exam rooms, lab equipment, consultation desks. No patients in frame.
• Team-led credibility framing — physician name, credentials, state license number on the landing page. Builds trust without making clinical claims.
• Consultation as the offer— "Book a 30-minute medical consultation. Discuss whether [category] is right for you." The clinic visit, not the prescription.
• Process-oriented copy— "Bloodwork → physician review → personalized protocol" reads as a clinical process, not a sales funnel.
• Geographic and category audience targetinginstead of interest- or demographic-attribute targeting. Lookalikes seeded from prior consults are generally safer than interest stacks like "weight loss" or "testosterone."

What clinics should do this week

1. Audit your current active ad set against the 9 clauses above.Anything that hits one or more clauses, pause and rebuild before it gets disapproved (and lowers your account quality score).
2. Verify LegitScript certification statusif you advertise compounded medications. Without it, you're one report away from suspension regardless of creative quality.
3. Rebuild your landing page to match.The LP is where Meta's automated review looks last and most carefully. If the LP has before/afters, pricing on prescription medications, or implied individual outcomes, the ad fails even if the creative is clean.
4. Move share of spend to Google Search. For medical-intent queries, Google currently allows more direct condition and treatment language (provided LegitScript is in place) and converts at a fundamentally higher rate than Meta does. Most of our clinics in 2026 are running 60/40 Google/Meta or heavier.

The bottom line

The 2026 update didn't close peptide clinics out of paid social — it closed generic wellness creative out. Clinics that built ad systems on before/after imagery and personal-state hooks are starting from zero. Clinics that built around clinical credibility and consultation-led offers were barely affected. The pattern that wins from here forward is more boring, more medical, and slower to produce — but it's the one that survives the review queue and the next policy update.

Frequently asked questions